← Back to all trials
Enrolling By Invitation
NCT07099404
Parathyroid Adenoma Detection With Rubidium-82 Imaging
Conditions: Parathyroid Adenomas, Hyperparathyroidism, Primary
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Enrollment: 20
Sponsor: Matthieu Pelletier-Galarneau, MD MSc
Location: Montreal Heart Institute Montreal Quebec
Summary
Assess the uptake of rubidium-82 in parathyroid adenomas.
Eligibility Criteria
Inclusion Criteria:
1. Age ≥ 18y
2. Ability to undergo imaging logistics
3. Ability to provide informed consent
4. Biochemical evidence of primary hyperparathyroidism
5. Documented parathyroid adenoma on prior 18F-fluorocholine imaging
Exclusion Criteria:
1. Normocalcemic primary hyperparathyroidism
2. Breastfeeding or pregnancy
3. Claustrophobia or inability to undergo imaging logistics
4. Any other history, condition, therapy, or uncontrolled intercurrent illness, which could in the opinion of the investigator affect compliance with study requirements or which would make the participant unsuitable for this study
Source: ClinicalTrials.gov (NCT07099404). StuddyBuddy aggregates publicly available trial information.
